About your Search

20120925
20121003
Search Results 0 to 3 of about 4
of georgetown's institute for law, science and global security. and i apologize if i butchered your last names. we will correct that in the feeds. >> it's great to be with all of you this morning i want to issue an apology if any of you are a twitter follower of mine. i have about 11,000 of them, and i guess yesterday they all got a little telling them that it just seemed and in this fantastic video. if you just clicked right your they could see it. at i think there is of a thousand friends, cycling through, this is the first time, it's ironic that i've ever fallen for one of the sort of cyber gags. i don't know what information they got from the, but nonetheless i wanted to kind of mentioned it and out myself as someone who is falling prey to the very folks out in cyber land. we have with us as mentioned katherine as executive director of georgetown institute for law, science and global security. she directs the global, george and cybersecurity project, and she also interestingly in the past, work with someone i'm well acquainted with, brent scowcroft from 2002-2006 as counsel to the presiden
that have not been here before, is a science and technology not for profit policy think tank if you will win the washington, d.c. area that focuses on how science and technology affect the national security. for quite some time we have studied issues in and around what people callasymmetric threats and most importantly, terrorism. this past year professor alexander and i released our second volume on al qaeda about 11 years after the first volume on al qaeda right before 9/11, and we would like to call your attention to it. there are copies available year and of course available on the web at amazon always good things and i want to highlight it today because it is more of a gift we are going to give to our panel members for taking the time of their busy schedules to the very least i can promise you a good sleep if you read it. [laughter] the second look at the potomac institute has been involved in over this past year is an effort with the bechtel corporation to look at the cyber issue, in particular the seibu doctrine. that volume edited by tim and i is in the publication of you have on you
before, is a science and technology, not for profit policy think tank, if you will for the washington, d.c., area that focuses on how science and technology affects our national security. for quite some time, we have been involved in the study of issues in and around what people call acementic threats. and most importantly terrorism. this past year, professor al sander an i realize released our second volume on al qaeda about the first volume on al qaeda right before 9/11. i would like to call your attention to it. there are copies available here and on the web and amazon. all the good things. i want to highlight it today. it's one of the gifts we are going to give to the members for takes the time out of their busy schedule to join us today. i can patrol you a good sleep if you read it. [laughter] the second work that the institute has been evolved in is the wefort the corporation to look at the cyber issue in particular cyber doctorate. that volume ed kitted by tim and i is in publication as we speak. so you a short flier of that summarizes what is in the volume. it will be out shortly
to actually do something that will be good for patients and good for science going forward so this is the one thing that didn't make it. the other little thick that didn't make it is now the safe dosage act, passed in the last minute, by the senate, and that's awaiting the president's signature, but one of the things that's necessary in terms of the resources is that this has to be a global enterprise. one of the things that is happening globally is the leading pharmaceutical companies in the united states, in europe, in japan have banded together to work with interpol to ensure they have enough resources to go after the bad guys around the world, and we've just started that. i think we're going to kick that off here next month. we've been discussing this with interpol, and we think we have a good program to help country's specific enforcement agencies with the global respective of interpol. yes, it costs money. it is money well spent, but more importantly, it gets us the heart of the trust that patients have to have in our medicines. >> ralph, i know as we've worked on the partnership and bu
Search Results 0 to 3 of about 4